• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Roopa Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Sree Rayalseema
  • BSE Code : 5239.0
  • ISIN : INE443C01010
56.33 1 (2.33%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    56.00

  • Today’s High

    59.00

  • Open

    58.98

  • Perv Close

    55.05

  • 52W Low

    47.26

  • 52W High

    114.90

Key Indicators

  • P/E(TTM)

    21.75

  • Mar.Cap (₹Cr.)

    44.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    22.24

  • Debt-Equity Ratio

    2.33

  • AGM Date

    01-Aug-2025

  • EPS

    2.59

  • P/E Ratio

    21.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    44.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.87

  • BV (₹)

    22.20

  • Sales( ₹ in Cr.)

    120.69

  • NP (in Cr.)

    2.03

  • NP Var(%)

    41.0

  • Div%

    0.0

  • CPS (₹)

    3.70

  • EPS (₹)

    2.60

  • Traded Value (₹ in Lakhs)

    44.31

  • 52 Week High

    114.90

  • 52 Week Low

    47.26

  • Price BSE

    56.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    44.31

  • P/C Ratio

    15.20

  • P/E Ratio

    21.60

  • Price Vs.BV

    2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 70.43 76.17 51.21 28.61 27.65 30.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.43 76.17 51.21 28.61 27.65 30.15
Other Income 1.13 0.65 0.06 0.08 1.09 0.28
Stock Adjustments 9.75 3.64 -6.68 4.88 2.20 2.43
Total Income 81.31 80.46 44.59 33.57 30.94 32.86
EXPENDITURE :            
Raw Materials 64.37 65.12 33.17 22.23 19.79 25.14
Power and Fuel Cost 2.87 2.71 1.90 2.14 2.64 1.84
Employee Cost 3.47 3.24 2.21 3.77 2.36 0.93
Other Manufacturing Expenses 2.47 2.48 1.97 1.20 1.29 1.04
Selling and Administration Expenses 1.91 1.71 1.30 1.26 1.75 1.08
Miscellaneous Expenses 0.65 0.65 0.54 0.16 0.18 0.04
Employee Benefit Expenses 3.47 3.24 2.21 3.77 2.36 0.93
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 75.73 75.92 41.08 30.77 28.01 30.07
Operating Profit 5.57 4.54 3.50 2.80 2.92 2.78
Interest 2.52 1.84 1.21 1.06 1.36 1.42
Gross Profit 3.05 2.70 2.29 1.74 1.56 1.36
Depreciation 0.87 0.89 0.93 0.81 0.76 0.57
Profit Before Tax 2.18 1.81 1.36 0.93 0.80 0.79
Current Tax 0.66 0.44 0.40 0.22 0.10 0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 0.01 -0.05 0.00 0.33 0.04
Reported Net Profit 1.52 1.35 1.02 0.72 0.37 0.60
Extraordinary Items 0.08 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 1.44 1.35 1.02 0.72 0.37 0.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 5.51 4.16 2.91 2.20 2.06 1.45
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7.03 5.51 3.93 2.91 2.43 2.06
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.93 1.72 1.29 0.91 0.47 0.77
Earnings Per Share(Adj)-Unit Curr 1.93 1.72 1.29 0.91 0.47 0.77
Book Value 19.67 17.73 16.00 14.70 13.73 13.25
Book Value(Adj)-Unit Curr 19.67 17.73 16.00 14.70 13.73 13.25

Shareholding Pattern

  • Promoter Group

    48.03%

  • Public Share Holding

    51.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,913,617 37.04 2,913,617 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 864,047 10.99 864,047 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,777,664 48.03 3,777,664 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20,000 0.25 0 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,250 0.26 250 2
2] Non Institution
Bodies Corporate 230,574 2.93 71,774 42
Clearing Members 900 0.01 900 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 615,054 7.82 69,454 220
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,405,151 17.86 1,340,751 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,815,927 23.09 1,214,742 3,722
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,067,606 51.71 2,697,621 3,995
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,865,520 100.00 6,475,535 4,002

Company Background

Roopa Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Roopa Industries Ltd
  • BSE Code : 5239.0
  • ISIN : INE443C01010

  • Incorporation Year

    1985

  • Registered Office

    17/745 Alur Road
    Kurnool District, ADONI,
    Andhra Pradesh-518301

  • Telephone

  • FAX

    91-40-23310379

  • Chairman

    T G Raghavendra

  • Managing Director

    T G Raghavendra

  • Company Secretary

    I V Lakshmi

  • Auditor

    S T Mohite & Co/Yelamanchi & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Roopa Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Roopa Industries 56.33 71.55 70.43 21.75 12.51
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10